# HOXC6

## Overview
The HOXC6 gene encodes the homeobox C6 protein, a transcription factor that plays a pivotal role in the regulation of gene expression during embryonic development and in adult tissues. As a member of the homeobox gene family, HOXC6 is characterized by a conserved homeodomain that facilitates its binding to specific DNA sequences, thereby modulating the transcription of target genes. The protein is primarily involved in processes such as cell differentiation and proliferation, particularly influencing the development of the nervous system and skeletal structures. In addition to its developmental roles, HOXC6 is implicated in various pathological conditions, including cancer, where it can affect tumor progression and the tumor microenvironment through its regulatory functions (Chariot1998Molecules; Qi2021The; Smith2019A).

## Structure
The HOXC6 protein is a transcription factor belonging to the homeobox gene family, characterized by a conserved 61-amino acid homeodomain responsible for DNA binding (Chariot1998Molecules). This homeodomain is a highly conserved DNA-binding region, allowing the protein to modulate the expression of various target genes (CHARIOT1996Cloning). The primary structure of HOXC6 includes this conserved homeodomain, and the protein is translated from two distinct transcripts, resulting in polypeptides with different N-terminal regions due to the use of different initial ATG codons (Chariot1998Molecules; CHARIOT1996Cloning).

The secondary structure of the homeodomain typically involves alpha helices, forming a helix-turn-helix motif, which is a common feature in the tertiary structure of homeodomain proteins. The HOXC6 protein also contains a pentapeptide sequence required for protein interactions, which may involve other homeodomain-containing proteins and cofactors like Pbx proteins, contributing to a combinatorial effect in gene regulation (Chariot1998Molecules).

Post-translational modifications of HOXC6 may include phosphorylation, although specific details on these modifications are not provided in the context. The existence of splice variant isoforms is suggested by the presence of two distinct transcripts, which may be generated from two promoters or through alternative splicing (CHARIOT1996Cloning).

## Function
HOXC6 (homeobox C6) is a transcription factor that plays a significant role in regulating gene expression during embryonic development. It is part of the homeobox gene family, which is crucial for the proper spatial arrangement of body segments. In healthy human cells, HOXC6 is involved in cell differentiation and proliferation, particularly influencing the development of the nervous system and skeletal structures. The protein is typically active in the nucleus, where it binds to DNA to modulate the transcription of target genes (Smith2019A).

HOXC6 is expressed in various adult tissues and is involved in maintaining cell identity and differentiation potential. It provides positional identity during development, which is retained in adult stem cells and influences their differentiation (Smith2019A). The expression patterns of HOXC6 suggest its involvement in early steps of erythroid colony-forming unit proliferation, indicating a role in cellular differentiation (CHARIOT1996Cloning).

The molecular activities of HOXC6 include its ability to repress transcription from a HOX binding sequence, as demonstrated in studies involving breast cancer cells (CHARIOT1996Cloning). This repressive function highlights its potential role in regulating gene expression networks critical for normal cellular function and development.

## Clinical Significance
HOXC6 (homeobox C6) is implicated in various cancers through alterations in its expression and interactions. In hepatocellular carcinoma, HOXC6 promotes cancer invasion by inducing epithelial-mesenchymal transition (EMT), characterized by the negative regulation of CDH1 and positive regulation of vimentin and MMP-9, which are crucial for cancer cell migration and invasion (Paço2020Roles). In colorectal cancer (CRC), HOXC6 is significantly overexpressed compared to normal tissues, correlating with a worse prognosis. High HOXC6 expression in stage IV CRC is associated with poor outcomes and increased immune cell infiltration, including CD4+ T cells, neutrophils, and dendritic cells, but not CD8+ T cells (Qi2021The). This overexpression is linked to changes in pathways related to chemokine signaling and inflammation, suggesting a role in remodeling the tumor immune microenvironment (Qi2021The).

In nasopharyngeal carcinoma, HOXC6 is involved in autophagy and apoptosis regulation, where its inhibition by miR-185 promotes these processes through the TGF-β1/mTOR pathway (Li2019The). In prostate cancer, HOXC6 acts as an apoptosis-suppressor gene, regulating BCL-2 expression and suppressing NEP/MME and IGFBP-3 genes, contributing to cancer progression (Li2019The). These findings highlight HOXC6's role in cancer progression and its potential as a therapeutic target.

## Interactions
HOXC6 is a transcription factor that participates in various interactions with proteins and nucleic acids, influencing gene expression and cellular processes. It functions as a transcriptional regulator by binding to specific DNA sequences, such as the promoter region of the neural cell adhesion molecule (N-CAM). The HOXC6 protein specifically interacts with the homeodomain binding site I (HBS-I) in the N-CAM promoter, which is crucial for transcriptional activation. This interaction is mediated by the DNA-binding domain of HOXC6, and mutations in the TAAT core sequences of HBS-I significantly affect its binding affinity (Jones1993Binding).

HOXC6 also engages in protein-protein interactions, which are essential for its functional specificity. These interactions often involve other HOX family members and cofactors, although many of these cofactors remain unidentified. The protein contains a conserved homeodomain sequence that facilitates DNA binding and a pentapeptide sequence required for interaction with other proteins, such as Pbx, suggesting a combinatorial effect in gene regulation (Chariot1998Molecules).

In prostate cancer cells, HOXC6 co-binds with other transcription factors like FOXA1 and AR, often at distal intergenic or intronic regions. These interactions are implicated in altering the prostate transcriptome and may contribute to cancer progression (Luo2020Genomewide).


## References


[1. (Jones1993Binding) F S Jones, B D Holst, O Minowa, E M De Robertis, and G M Edelman. Binding and transcriptional activation of the promoter for the neural cell adhesion molecule by hoxc6 (hox-3.3). Proceedings of the National Academy of Sciences, 90(14):6557–6561, July 1993. URL: http://dx.doi.org/10.1073/pnas.90.14.6557, doi:10.1073/pnas.90.14.6557. This article has 71 citations.](https://doi.org/10.1073/pnas.90.14.6557)

[2. (Qi2021The) Lina Qi, Chenyang Ye, Ding Zhang, Rui Bai, Shu Zheng, Wangxiong Hu, and Ying Yuan. The effects of differentially-expressed homeobox family genes on the prognosis and hoxc6 on immune microenvironment orchestration in colorectal cancer. Frontiers in Immunology, December 2021. URL: http://dx.doi.org/10.3389/fimmu.2021.781221, doi:10.3389/fimmu.2021.781221. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2021.781221)

[3. (Smith2019A) Jessica Smith, Ahmad Zyoud, and Cinzia Allegrucci. A case of identity: hox genes in normal and cancer stem cells. Cancers, 11(4):512, April 2019. URL: http://dx.doi.org/10.3390/cancers11040512, doi:10.3390/cancers11040512. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers11040512)

[4. (Luo2020Genomewide) Zhifei Luo and Peggy J. Farnham. Genome-wide analysis of hoxc4 and hoxc6 regulated genes and binding sites in prostate cancer cells. PLOS ONE, 15(2):e0228590, February 2020. URL: http://dx.doi.org/10.1371/journal.pone.0228590, doi:10.1371/journal.pone.0228590. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0228590)

[5. (CHARIOT1996Cloning) Alain CHARIOT, Vincent CASTRONOVO, Phuonc LE, Claudette GILLET, Mark E. SOBEL, and Jacques GIELEN. Cloning and expression of a new hoxc6 transcript encoding a repressing protein. Biochemical Journal, 319(1):91–97, October 1996. URL: http://dx.doi.org/10.1042/bj3190091, doi:10.1042/bj3190091. This article has 21 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj3190091)

[6. (Chariot1998Molecules) Alain Chariot and Jacques Gielen. Molecules in focus the hoxc6 homeodomain-containing proteins. The International Journal of Biochemistry &amp; Cell Biology, 30(6):651–655, June 1998. URL: http://dx.doi.org/10.1016/s1357-2725(97)00136-2, doi:10.1016/s1357-2725(97)00136-2. This article has 6 citations.](https://doi.org/10.1016/s1357-2725(97)00136-2)

[7. (Li2019The) Bo Li, Qilai Huang, and Gong-Hong Wei. The role of hox transcription factors in cancer predisposition and progression. Cancers, 11(4):528, April 2019. URL: http://dx.doi.org/10.3390/cancers11040528, doi:10.3390/cancers11040528. This article has 122 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers11040528)

[8. (Paço2020Roles) Ana Paço, Simone Aparecida de Bessa Garcia, Joana Leitão Castro, Ana Rita Costa-Pinto, and Renata Freitas. Roles of the hox proteins in cancer invasion and metastasis. Cancers, 13(1):10, December 2020. URL: http://dx.doi.org/10.3390/cancers13010010, doi:10.3390/cancers13010010. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13010010)